a selective matriptase inhibitor blocks tumor growth and metastasis while displaying potent antiangiogenic activity in an orthotopic murine renal cell cancer model
暂无分享,去创建一个
T. Ikonen | M. Ramachandra | H. Subramanya | G. Wohlfahrt | A. Moilanen | R. Ramachandra | L. Satyam | R. Goswami | Chakshusmathi Ghadiyaram | Jwala Nagaraj | K. Subbarao | P. Kallio
[1] T. Kamoto,et al. Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis , 2014, Human Cell.
[2] T. Ikonen,et al. Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy. , 2014, Bioorganic & medicinal chemistry.
[3] M. Ramachandra,et al. Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors. , 2013, ACS medicinal chemistry letters.
[4] J. Abrams,et al. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer. , 2010, Cancer research.
[5] S. B. Kim,et al. Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential , 2010, Molecules and cells.
[6] J. P. Hobson,et al. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice , 2009, Development.
[7] D. Qian,et al. Vascular Endothelial Growth Factor Trap Blocks Tumor Growth, Metastasis Formation, and Vascular Leakage in an Orthotopic Murine Renal Cell Cancer Model , 2007, Clinical Cancer Research.
[8] R. Dickson,et al. Matriptase activates stromelysin (MMP‐3) and promotes tumor growth and angiogenesis , 2006, Cancer science.
[9] K. Uhland. Matriptase and its putative role in cancer , 2006, Cellular and Molecular Life Sciences CMLS.
[10] W. Bode,et al. Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase. , 2006, Journal of medicinal chemistry.
[11] Jong-Shiaw Jin,et al. Expression of Serine Protease Matriptase in Renal Cell Carcinoma: Correlation of Tissue Microarray Immunohistochemical Expression Analysis Results with Clinicopathological Parameters , 2006, International journal of surgical pathology.
[12] B. Nielsen,et al. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. , 2005, Genes & development.
[13] D. Agus,et al. CVS‐3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts , 2004, The Prostate.
[14] Chen-Yong Lin,et al. Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase* , 2004, Journal of Biological Chemistry.
[15] S. Wahl,et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis , 2002, Oncogene.
[16] Baljit Singh,et al. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] I. Enyedy,et al. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. , 2001, Journal of medicinal chemistry.
[18] K. Shigemasa,et al. Ovarian Tumor Cells Express a Transmembrane Serine Protease: A Potential Candidate for Early Diagnosis and Therapeutic Intervention , 2000, Tumor Biology.
[19] R. Dickson,et al. Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease* , 2000, The Journal of Biological Chemistry.
[20] Jennifer L. Harris,et al. Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.
[21] C. Garlanda,et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.
[22] Rajnish A. Gupta,et al. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. , 2001, Cancer research.